ALL Adult
Adult acute lymphoblastic leukemia includes genetically diverse subtypes, with probe panels supporting investigation of recurrent alterations tied to risk and disease behavior.
Discover expertly designed FISH probes tailored to specific disease areas, making it easier to move from question to assay with confidence. From leukemias and lymphomas to solid tumor applications, this library is built to help your team find the right starting point quickly.
Adult acute lymphoblastic leukemia includes genetically diverse subtypes, with probe panels supporting investigation of recurrent alterations tied to risk and disease behavior.
Acute lymphoblastic leukemia accounts for most childhood leukemia diagnoses, with outcomes and risk groups shaped heavily by distinct underlying chromosomal lesions.
BCR-ABL1 fusion defines a high-risk subset of adult acute lymphoblastic leukemia and remains a major focus for disease classification and targeted investigation.
Acute myeloid leukemia panels help profile recurrent chromosome changes and structural abnormalities that shape diagnosis, classification, and downstream testing workflows.
Barrett’s esophagus can progress to esophageal adenocarcinoma, and FISH helps reveal genomic instability and early high-risk changes tied to that transition.
Bladder cancer research often focuses on copy number gains, losses, and locus-specific abnormalities that can help distinguish disease-associated genomic patterns.
Breast cancer probe collections support evaluation of clinically relevant amplifications and structural events involved in tumor biology and disease stratification.
Chronic lymphocytic leukemia is the most common adult leukemia, with recurrent deletions involving 11q, 13q, and 17p, plus trisomy 12 in a meaningful subset of cases.
Eosinophilia-associated panels help investigate rearrangements and chromosomal events linked to myeloid and lymphoid neoplasms with eosinophilic involvement.
Glioblastoma studies frequently examine hallmark gains, losses, and oncogene-associated changes that contribute to aggressive tumor progression in the central nervous system.
Lung cancer probe panels support investigation of recurrent amplifications, deletions, and other genomic changes relevant to tumor classification and translational research.
Myelodysplastic syndrome panels help assess recurrent chromosome losses, gains, and structural abnormalities associated with clonal hematopoietic disease.
Melanoma-focused probes support evaluation of genomic instability and copy number changes that can help distinguish malignant progression in melanocytic lesions.
Multiple myeloma is driven by a complex landscape of copy number changes, IGH translocations, and tumor suppressor losses that influence progression and treatment response.
IGH rearrangements are early disease-initiating events in multiple myeloma and MGUS, with recurrent partners including MAF, MAFB, CCND1, and FGFR3.
Non-Hodgkin lymphoma panels help study recurrent rearrangements and copy number changes across genetically distinct lymphoma subtypes.
Ovarian cancer collections support investigation of genomic gains, losses, and locus-specific abnormalities involved in tumor development and progression.
Prenatal probe panels support targeted chromosome analysis for common aneuploidies and other abnormalities relevant to rapid prenatal assessment workflows.
T-cell acute lymphoblastic leukemia panels help investigate recurrent chromosomal changes and gene-associated abnormalities involved in leukemic transformation.
If you don't have an account with us yet, click the button below to create a new one. We will verify your information before you can begin placing orders. In the meantime, feel free to start adding items to your cart!
Create New Account